1 |
29 |
F |
Beta-thalassemia Hb E |
No |
Iron overload |
Lea, Leb, E, Mia, Fyb, Dia
|
E–, K–, Fy(b–), S–, Mi(a–), Di (a–) |
4.5 |
5.5 |
2 |
12 |
M |
Homozygous beta-thalassemia |
Yes (3 years before the study) |
Iron overload, chronic portal, and splenic vein |
Mia, Leb, Jkb, unidentifed |
E–, K–, Fy(b–), Jk(b–), Mi(a–), Di (a–) |
7.2 |
9.1 |
3 |
3 |
F |
Homozygous beta-thalassemia |
No |
Iron overload |
E, c, Mia, S |
E–, c–, K–, Fy(b–), N–, S–, Mi(a–), Di (a–) |
8.9 |
8.6 |
4 |
36 |
F |
Beta-thalassemia Hb E |
No |
Iron overload |
E, c, Mia, S, Jkb
|
E–, c–, K–, Jk(b–), Fy(b–), N–, S–, Mi(a–), Di (a–) |
6.8 |
7.2 |
5 |
40 |
F |
Homozygous beta-thalassemia |
No |
Iron overload |
M, c, K, Jkb, Mia
|
E–, c–, K–, Jk(b–), M–, S–, Mi(a–), Di (a–) |
7.3 |
6.9 |
6 |
39 |
F |
Beta-thalassemia Hb E |
Yes (23 years before the study) |
Iron overload |
Lea, Leb, S, unidentifed |
K–, Fy(b–), N–, S–, Di (a–) |
6.9 |
7.4 |
7 |
14 |
M |
Beta-thalassemia Hb E |
No |
Iron overload |
E, c, Mia, Dia
|
E–, c–, K–, Fy(b–), N–, S–, Mi(a–), Di (a–) |
7.9 |
7.7 |
8 |
20 |
F |
Homozygous beta-thalassemia |
Yes (16 years before the study) |
Iron overload, transaminitis |
E, c, S, Chido |
E–, c–, K–, N–, S–, Di (a–) |
8.7 |
7.4 |
9 |
27 |
M |
Homozygous beta-thalassemia |
Yes (23 years before the study) |
Iron overload |
E, c, Lea, Fyb
|
E-, c-, K-, Fy(b-), S-, Mi(a-), Di(a-) |
4.7 |
3.6 |
10 |
42 |
F |
Beta-thalassemia Hb E |
No |
Iron overload |
Jka, Mia, unidentifed |
C–, K–, Fy(b–), Jk(a–), M–, S–, Mi(a–), Di (a–) |
5.8 |
6.1 |
11 |
53 |
F |
Hb H Constant Spring |
Yes (20 years before the study) |
Iron overload, pulmonary hypertension, chronic deep vein thrombosis, and pulmonary embolism |
E, c, Mia
|
E–, c–, K–, S–, Mi(a–), Di (a–) |
9.8 |
9.7 |
12 |
44 |
M |
Homozygous beta-thalassemia |
Yes (during the study) |
Iron overload, extramedullary hematopoiesis at spine causing neurodefciency |
E, c, Mia
|
E–, c–, K–, Fy(b–), Mi(a–), Di (a–) |
6.3 |
7.3 |
13 |
58 |
F |
Beta-thalassemia Hb E |
Yes (13 years before the study) |
Iron overload |
E, auto-C |
E–, c–, K–, Jk(b–), Fy(b–), S–, Mi(a–), Di (a–) |
8.1 |
7.6 |
14 |
20 |
F |
Homozygous beta-thalassemia |
Yes (6 years before the study) |
Iron overload, pulmonary hypertension |
Mia, S |
E-, c-, K-, Jk(b-), S-, Mi(a-) |
6.5 |
7.3 |
15 |
20 |
F |
Beta-thalassemia Hb E |
No |
Iron overload, epilepsy |
E, c |
E–, c–, K–, S–, Mi(a–), Di (a–) |
3.7 |
5.1 |
16 |
2 |
F |
Homozygous beta-thalassemia |
No |
None |
Jka, unidentifed |
K–, Jk(a–), N–, S–, Mi(a–), Di (a–) |
9.0 |
9.2 |
17 |
19 |
F |
Beta-thalassemia Hb E |
No |
Iron overload |
E, unidentifed |
E–, c–, K–, Jk(b–), Fy(b–), M–, S–, Mi(a–), Di (a–) |
7.9 |
8.3 |
18 |
7 |
F |
Beta-thalassemia Hb E |
No |
Iron overload |
Chido |
E–, c–, K–, Jk(b–), Fy(b–), S–, Mi(a–), Di (a–) |
8.7 |
9.1 |
19 |
11 |
F |
Beta-thalassemia Hb E |
No |
Iron overload, ventricular septal defect/atrial septal defect |
Mia
|
E–, K–, N–, S–, Mi(a–), Di (a–) |
7.6 |
7.3 |
20 |
35 |
M |
Beta-thalassemia Hb E |
Yes (22 years before the study) |
Iron overload |
E |
E-, c-, K-, Fy(b-), S-, Mi(a-), Di(a-) |
3.7 |
4.9 |
21 |
28 |
F |
Beta-thalassemia Hb E |
Yes (23 years before the study) |
Iron overload |
Nonspecifc cold |
E-, K-, Fy(b-), N-, S-, Mi(a-), Di(a-) |
8.5 |
8.9 |
22 |
6 |
F |
Homozygous beta-thalassemia |
No |
Iron overload |
No alloantibody |
E–, c–, K–, Jk(a–), N–, S–, Mi(a–), Di (a–) |
Patient did not receive regular transfusion before enrollment; excluded from study. |
23 |
17 |
F |
Beta-thalassemia Hb E |
No |
Iron overload |
No alloantibody |
E–, c–, K–, Fy(b–), N–, S–, Mi(a–), Di (a–) |
9.2 |
7.6 |
24 |
27 |
F |
Beta-thalassemia Hb E |
No |
Iron overload |
No alloantibody |
E–, c–, K–, Jk(b–), N–, S–, Mi(a–), Di (a–) |
Patient did not receive regular transfusion before enrollment; excluded from study. |